Latest Articles

21 hours, 22 minutes ago

Clifford Chance Selects Autonomy Introspect spacer

CAMBRIDGE, England and SAN FRANCISCO, Sept. 2 /PRNewswire/ -- Autonomy Corporation plc (LSE: AU. or AU.L), a global leader in infrastructure software for the enterprise, today announced that Clifford Chance ... RedOrbit News - Technology - 1 a.m. Thursday 2nd September 2010 PDT View Article Related Articles Email to Friend

1 day, 15 hours ago

Euro stocks boost drug sector spacer

BOSTON (MarketWatch) -- Large-cap European drug makers were on a roll early Wednesday, feeding off the momentum of a positive trading session for the broader market in Europe. Top gainers ... MarketWatch.com - MarketPulse - 6:55 a.m. Wednesday 1st September 2010 PDT View Article Related Articles Email to Friend

Autonomy Positioned in Leaders Quadrant of the 2010 Web Content Management Magic Quadrant spacer

CAMBRIDGE, England and SAN FRANCISCO, Sept. 1 /PRNewswire/ -- Autonomy Corporation plc (LSE: AU. or AU.L), a global leader in infrastructure software for the enterprise, today announced that it has ... RedOrbit News - Technology - 1 a.m. Wednesday 1st September 2010 PDT View Article Related Articles Email to Friend

2 days, 14 hours ago

Conway Reaches Settlement With GlaxoSmithKline for $3.75 Million spacer

Bizjournals -- Kentucky Attorney General Jack Conways office has reached a $3.75 million settlement between the state and GlaxoSmithKline PLC over the alleged deceptive or false marketing of the drugmakers ... BioSpace - 8 a.m. Tuesday 31st August 2010 PDT View Article Related Articles Email to Friend

GlaxoSmithKline, Valeant Pharmaceuticals International Face US Delay for Epilepsy Drug, Receives New PDUFA Date spacer

LONDON, RESEARCH TRIANGLE PARK, N.C., and ALISO VIEJO, Calif., Aug. 30 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK - News) and Valeant Pharmaceuticals International (NYSE:VRX - News) announced today the U.S. Food and ... BioSpace - 7:20 a.m. Tuesday 31st August 2010 PDT View Article Related Articles Email to Friend

Glaxo, Valeant face US delay for epilepsy drug spacer

GlaxoSmithKline PLC and Valeant Pharmaceuticals International say they may have to wait an extra three months for the U.S. regulatory review of their potential epilepsy treatment ezogabine. CNBC : All News, Video and Posts related to SECTOR: Health Care - 3:21 a.m. Tuesday 31st August 2010 PDT View Article Related Articles Email to Friend

Also reported by:
Glaxo, Valeant May Wait 3 More Months for Drug Review spacer

GlaxoSmithKline Plc and Valeant Pharmaceuticals International may have to wait an extra three months for a review of their experimental epilepsy medicine after U.S. regulators sought more time to study ... BusinessWeek.com -- Europe - 12:21 a.m. Tuesday 31st August 2010 PDT View Article Related Articles Email to Friend

3 days ago

Glaxo, Valeant May Wait 3 More Months for Epilepsy Drug Review spacer

GlaxoSmithKline Plc and Valeant Pharmaceuticals International may have to wait an extra three months for a review of their experimental epilepsy medicine after U.S. regulators sought more time to study ... BusinessWeek.com -- Europe - 9:46 p.m. Monday 30th August 2010 PDT View Article Related Articles Email to Friend

GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine spacer

LONDON, RESEARCH TRIANGLE PARK, N.C. and ALISO VIEJO, Calif., Aug. 30 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) and Valeant Pharmaceuticals International (NYSE: VRX) announced today the U.S. Food and Drug Administration ... RedOrbit - health - 5:15 p.m. Monday 30th August 2010 PDT View Article Related Articles Email to Friend

Conway reaches settlement with GlaxoSmithKline spacer

Kentucky Attorney General Jack Conway’s office has reached a $3.75 million settlement between the state and GlaxoSmithKline PLC over the alleged deceptive or false marketing of the drugmaker’s anti-nausea medications, ... National Business News | bizjournals - 11:50 a.m. Monday 30th August 2010 PDT View Article Related Articles Email to Friend

2,273 articles match your search

News Volume and Sentiment

Chart News Volume
News Sentiment Positive Negative

Related Organizations

Related People

Related Locations

Related Publishers